ILLUMINA, INC. is 6.6x more valuable than 10x Genomics, Inc. by market capitalization ($24.58 B vs $3.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TXG | ILMN |
|---|---|---|
| Market cap | $3.72 B | $24.58 B |
| US-listed rank | #1634 | #540 |
| Revenue (latest FY) | $642.82M | $4.34B |
| Net income (latest FY) | -$43.50M | $850.00M |
| Net margin | -6.8% | 19.6% |
| P/E (trailing FY) | - | 28.9 |
| SEC filings | 652 | 3,713 |
ILLUMINA, INC. is 6.6x more valuable than 10x Genomics, Inc. by market capitalization ($24.58 B vs $3.72 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while ILLUMINA, INC. reported $4.34B.
Full pages: 10x Genomics, Inc. and ILLUMINA, INC., or browse the full rankings.